StockData
Edwards Lifesciences Corp logo

Edwards Lifesciences Corp

EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3060% above fair value
$103.88−1.35 (-1.28%)

Close on Nov 19, 2026Market cap $59.88BP/E 59.7Yield –

Edwards Lifesciences Allowance for Credit Losses by Quarter

Allowance for Credit Losses (Doubtful Accounts Receivable) ($M)

Edwards Lifesciences Allowance for Credit Losses: $17M in Q3 2026, up 34.9% from a year earlier. That is the highest of the 55 quarters on record here.

Latest, Q3 2026
17
Period ended Sep 30, 2026
Change on a year earlier
+34.9%
12.6 in Q3 2025
History
55 quarters
Since Q1 2013
Sources
43
Documents cited below

Where the Q3 2026 figure comes from

Source: SEC Filing (0001099800-26-000054) ↗

Reported in Form 10-K / Form 10-Q Balance Sheet Footnote.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAllowance for Credit Losses (Doubtful Accounts Receivable) ($M)Year on yearSource
Q3 2026Sep 30, 202617+34.9%SEC Filing (0001099800-26-000054) ↗
Q2 2026Jun 30, 202616+26.0%SEC Filing (0001099800-26-000043) ↗
Q1 2026Mar 31, 202615.6+23.8%SEC Filing (0001099800-26-000026) ↗
Q4 2025Dec 31, 202515+29.3%SEC Filing (0001099800-26-000054) ↗
Q3 2025Sep 30, 202512.60.0%SEC Filing (0001099800-25-000062) ↗
Q2 2025Jun 30, 202512.7-8.6%SEC Filing (0001099800-25-000048) ↗
Q1 2025Mar 31, 202512.6-6.7%SEC Filing (0001099800-25-000023) ↗
Q4 2024Dec 31, 202411.6+41.5%SEC Filing (0001099800-26-000009) ↗
Q3 2024Sep 30, 202412.6+59.5%SEC Filing (0001099800-24-000086) ↗
Q2 2024Jun 30, 202413.9+71.6%SEC Filing (0001099800-24-000078) ↗
Q1 2024Mar 31, 202413.5+77.6%SEC Filing (0001099800-24-000039) ↗
Q4 2023Dec 31, 20238.20+3.8%SEC Filing (0001099800-25-000005) ↗
Q3 2023Sep 30, 20237.90+5.3%SEC Filing (0001099800-23-000039) ↗
Q2 2023Jun 30, 20238.10-5.8%SEC Filing (0001099800-23-000034) ↗
Q1 2023Mar 31, 20237.60-12.6%SEC Filing (0001099800-23-000021) ↗
Q4 2022Dec 31, 20227.90-15.1%SEC Filing (0001099800-24-000004) ↗

Cite this data

StockData. (2026). Edwards Lifesciences Allowance for Credit Losses ($M), quarterly Q1 2013–Q3 2026 [Data set]. Compiled from Edwards Lifesciences SEC filings and investor materials. https://stockdatahq.com/stocks/ew/kpis/res-ar-allow

See every metric in the Edwards Lifesciences KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?